Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Greistorfer, T; Jud, P.
Clinical characteristics of COVID-19 associated vasculopathic diseases.
Thromb J. 2023; 21(1): 61 Doi: 10.1186/s12959-023-00504-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz

Jud Philipp

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Coronavirus disease 19 (COVID-19) has shown to be an infectious disease affecting not only of the respiratory system, but also cardiovascular system leading to different COVID-19-associated vasculopathies. Venous and arterial thromboembolic events have been frequently described among hospitalized patients with COVID-19 and inflammatory vasculopathic changes have also been observed. Several of the reported COVID-19 associated vasculopathies exhibit differences on epidemiology, clinical characteristics and outcome compared to non-COVID-19 types. This review focuses on the epidemiology, clinical, diagnostic and therapeutic characteristics as well as outcome data of COVID-19 associated thromboembolic events and inflammatory vasculopathies, elaborating similarities and differences with non-COVID-19 cohorts.

Find related publications in this database (Keywords)

COVID-19

Venous thromboembolism

Arterial thromboembolism

Vasculitis

© Med Uni Graz • Imprint